EA Series Trust’s Pfizer PFE Stock Holding History

EA Series Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$8.97M	Buy	+244,678	New	+$9.52M	0.32%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EA Series Trust's PFE Position: Q2 2023 in Review

EA Series Trust opened a new position in Pfizer (PFE) in Q2 2023: 244,678 shares worth $8.97M. The stake represents 0.32% of the portfolio and ranks #44 among its holdings.

3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

EA Series Trust held 244,678 shares of Pfizer worth $8.97M as of Q2 2023.
Pfizer was a new EA Series Trust position in Q2 2023.
Pfizer made up 0.32% of EA Series Trust's portfolio in Q2 2023, its #44 holding.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.